APA (7th ed.) Citation

Liu, H., Zhou, C., Lu, J., Liu, Y., Zou, P., Zhu, L., . . . Han, B. Anlotinib enhances the efficacy of KRAS-G12C inhibitors through c-Myc/ORC2 axis inhibition in non-small cell lung cancer. Nature Publishing Group.

Chicago Style (17th ed.) Citation

Liu, Hongyu, Chao Zhou, Jun Lu, Yuqing Liu, Peichen Zou, Liang Zhu, Huimin Lei, and Baohui Han. Anlotinib Enhances the Efficacy of KRAS-G12C Inhibitors Through C-Myc/ORC2 Axis Inhibition in Non-small Cell Lung Cancer. Nature Publishing Group.

MLA (9th ed.) Citation

Liu, Hongyu, et al. Anlotinib Enhances the Efficacy of KRAS-G12C Inhibitors Through C-Myc/ORC2 Axis Inhibition in Non-small Cell Lung Cancer. Nature Publishing Group.